Stifel Financial Corp cut its position in BlackRock Health Sciences Term Trust (NYSE:BMEZ – Free Report) by 10.2% during the 4th quarter, according to the company in its most recent filing with the Securities & Exchange Commission. The fund owned 372,212 shares of the company’s stock after selling 42,134 shares during the quarter. Stifel Financial Corp’s holdings in BlackRock Health Sciences Term Trust were worth $5,360,000 at the end of the most recent quarter.
A number of other hedge funds and other institutional investors have also recently bought and sold shares of the company. Raymond James Financial Inc. bought a new stake in shares of BlackRock Health Sciences Term Trust during the fourth quarter valued at approximately $10,869,000. Absolute Investment Advisers LLC bought a new stake in BlackRock Health Sciences Term Trust during the 4th quarter valued at $3,941,000. Wolverine Asset Management LLC boosted its position in BlackRock Health Sciences Term Trust by 496.1% during the 4th quarter. Wolverine Asset Management LLC now owns 187,617 shares of the company’s stock worth $2,702,000 after acquiring an additional 156,141 shares during the period. Sit Investment Associates Inc. boosted its position in BlackRock Health Sciences Term Trust by 7.9% during the 4th quarter. Sit Investment Associates Inc. now owns 1,724,706 shares of the company’s stock worth $24,836,000 after acquiring an additional 125,599 shares during the period. Finally, Brooklyn FI LLC bought a new position in shares of BlackRock Health Sciences Term Trust in the fourth quarter worth $826,000.
BlackRock Health Sciences Term Trust Stock Performance
Shares of NYSE BMEZ opened at $14.28 on Wednesday. The firm’s 50-day simple moving average is $14.68 and its 200 day simple moving average is $15.27. BlackRock Health Sciences Term Trust has a fifty-two week low of $12.58 and a fifty-two week high of $16.75.
BlackRock Health Sciences Term Trust Cuts Dividend
About BlackRock Health Sciences Term Trust
BlackRock Health Sciences Trust II’s (BMEZ) (the ‘Trust’) investment objective is to provide total return and income through a combination of current income, current gains and long-term capital appreciation. The Trust seeks to achieve its investment objective by investing, under normal market conditions, at least 80% of its total assets in equity securities of companies principally engaged in the health sciences group of industries and equity derivatives with exposure to the health sciences group of industries.
See Also
- Five stocks we like better than BlackRock Health Sciences Term Trust
- Dividend Payout Ratio Calculator
- Don’t Be Fooled by the Bounce: The Market Storm Isn’t Over Yet
- What is a Dividend Harvesting Strategy and How Can Investors Profit from it?
- Coca-Cola Company Stock Can Bubble to New Highs This Year
- Earnings Per Share Calculator: How to Calculate EPS
- 3 Stocks Lifting 2025 Guidance Despite Market Jitters
Want to see what other hedge funds are holding BMEZ? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for BlackRock Health Sciences Term Trust (NYSE:BMEZ – Free Report).
Receive News & Ratings for BlackRock Health Sciences Term Trust Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for BlackRock Health Sciences Term Trust and related companies with MarketBeat.com's FREE daily email newsletter.